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Background: Hsp31 is a multifunctional cellular stress response protein. 
Results: Hsp31 is a stress-inducible chaperone that has substoichiometric activity on a wide spectrum of substrates, including 
prions and the non-physiological client, -synuclein. 
Conclusion: Hsp31 protects cells from -synuclein-mediated toxicity via chaperone activity and independently from enzymatic 
activity and autophagy.
Significance: This is the first characterization of the early acting and wide ranging chaperone activity of Hsp31. 
The Saccharomyces cerevisiae heat shock protein Hsp31 is a 
stress-inducible homodimeric protein that is involved in diauxic
shift reprogramming and has glyoxalase activity. We show that
substoichiometric concentrations of Hsp31 can abrogate aggrega-
tion of a broad array of substrates in vitro. Hsp31 also modulates 
the aggregation of -synuclein (Syn), a target of the chaperone
activity of human DJ-1, an Hsp31 homolog. We demonstrate that
Hsp31 is able to suppress the in vitro fibrillization or aggregation of 
Syn, citrate synthase and insulin. Chaperone activity was also 
observed in vivo because constitutive overexpression of Hsp31 
reduced the incidence of Syn cytoplasmic foci, and yeast cells 
were rescued from Syn-generated proteotoxicity upon Hsp31
overexpression. Moreover, we showed that Hsp31 protein levels 
are increased by H2O2, in the diauxic phase of normal growth con-
ditions, and in cells under Syn-mediated proteotoxic stress. We
show that Hsp31 chaperone activity and not the methylglyoxalase
activity or the autophagy pathway drives the protective effects. We
also demonstrate reduced aggregation of the Sup35 prion domain,
PrD-Sup35, as visualized by fluorescent protein fusions. In addi-
tion, Hsp31 acts on its substrates prior to the formation of large
aggregates because Hsp31 does not mutually localize with prion
aggregates, and it prevents the formation of detectable in vitro 
Syn fibrils. These studies establish that the protective role of
Hsp31 against cellular stress is achieved by chaperone activity that
intervenes early in the protein misfolding process and is effective
on a wide spectrum of substrate proteins, including Syn and prion 
proteins. 
Heat shock proteins (HSPs)5 protect living cells against envi-
ronmental stress and promote cell survival. This function is 
evolutionarily conserved throughout different organisms. HSPs
interact with misfolded proteins and process them using several
mechanisms, including chaperone functions to prevent mis-
folded protein aggregation, unraveling protein aggregates, or 
carrying out protease functions to eliminate irreversibly dam-
aged proteins. The effect of HSPs in maintaining cellular home-
ostasis throughout the protein folding process is essential to 
preventing diseases associated with protein misfolding and 
aggregation, such as Alzheimer disease, Parkinson disease (PD),
and Huntington disease. HSPs involved in counteracting these
protein inclusions are currently under intensive study (1).
Among the neurodegenerative diseases, PD is the second 
most common neurodegenerative disorder that occurs in 
elderly individuals 50 years or older, and no cure is currently
known (2, 3). High levels of reactive oxygen species (ROS), dys-
functional mitochondria, and the aggregation of Syn are 
observed in PD (4 – 8). DJ-1, a gene linked to familial forms of
PD, has been found to be involved in oxidative insults, protea-
some degradation, and protein folding and is the focus of exten-
sive studies to understand its functions in regulating levels of 
Syn aggregation (9 –14).
Human DJ-1, yeast Hsp31 (YDR533c), and Escherichia coli 
Hsp31 (hchA or yedU) are members of the DJ-1/PfpI/ThiJ
superfamily (10, 15, 16). Crystal structures of Hsp31 show that
it contains a cysteine catalytic triad that is conserved in the 
DJ-1/PfpI/ThiJ family (17, 18). E. coli hchA is a close ortholog
with yeast Hsp31, and they share superimposable active sites in
each monomer, but their quaternary structures appear to be 
different (17, 19). This protein family is of biomedical impor-
tance due to the role these proteins play in chaperone-like and 
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TABLE 1 
Yeast strains 
Strain Genotype Source/Reference 
BY4741 MATa his3, leu2, met15, ura3, ARL1, GCS1, ARL3, ARF3, YPT6, IMH1, SYS1, GAS1 Invitrogen 
W303-1A MATa can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1 ade2-1 R. Rothstein 
W303-hsp31 W303-1A hsp31:natMX This study 
W303-HSP31-9myc W303-1A HSP31 9myc::kanMX-  This study 
W303–1xSyn W303 GAL Syn-YFP-  at URA3 or TRP1 loci J-C. Rochet (75, 76) 
W303–2xSyn W303 GAL Syn-YFP-  at URA3 GAL Syn-CFP-  at TRP1 loci J-C. Rochet 
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cytoprotective activities (15, 19). Despite the shared structural
similarity, this family can be further subcategorized into three
classes according to the structural and functional properties of
the proteins or into five subclasses by protein sequence align-
ments (15, 19). The cellular functions of DJ-1 and E. coli hchA 
have been characterized, and their multifunctional roles in 
mediating oxidative stress, chaperone-like activity, methylg-
lyoxalase activity, and cytoprotection have been described (10,
15, 16, 19). There has been limited characterization of the cel-
lular functions of Hsp31, but several recent studies have dem-
onstrated that it has glyoxylase activity (20), chaperone activity
(21), and a role in autophagy (22).
Yeast PD models have been used to study the mechanism of
the sporadic and familial forms of PD (23–25). We are extend-
ing the utility of these yeast models by investigating the biolog-
ical activities of yeast Hsp31. Hsp31 appears to be a stress-
inducible 26-kDa protein based on several large scale studies 
indicating that yeast Hsp31 is up-regulated when cells are 
exposed to environmental stress (26 –29). For example, Hsp31
was implicated to be protective against ROS because an hsp31 
strain was more sensitive to oxidative stress (26). HchA has 
structural similarity to Hsp31 and is established as having chap-
erone activities, suggesting that Hsp31 could act similarly; how-
ever, this has yet to be confirmed. The evidence for a role in 
stress response, possible chaperone activity, methylglyoxalase
activity, and cross-talk with the autophagy pathway led us to 
investigate these activities of Hsp31 in modulating Syn cyto-
plasmic foci formation and prion aggregation. Syn is not pres-
ent in yeast and hence is a non-physiological substrate, but it
mimics physiologically relevant activity based on its localiza-
tion and toxicity, and we capitalized on these features. There-
fore, we designed a set of biochemical, genetic, and cell biology
experiments to demonstrate the role of Hsp31 chaperone activ-
ity in protecting cells from Syn-mediated cytotoxicity. We 
also demonstrate that Hsp31 has methylglyoxalase activity that
converts methylglyoxal (MGO) substrate to D-lactate, but this 
enzyme activity is not essential for protecting against Syn-
mediated cytotoxicity. 
Experimental Procedures 
Yeast Cell Growth Conditions 
Yeast media were prepared according to Amberg et al. (30). 
Liquid yeast extract/peptone dextrose medium contained 
Bacto yeast extract (1%; Fisher), Bacto peptone (2%; Fisher), and
glucose (2%; Fisher). Synthetic dextrose (SD) minimum liquid
medium was made of 0.17% Difco yeast nitrogen base (without
amino acids) and 2% glucose and supplemented with necessary
amino acids for auxotrophic strains needed at concentrations
described previously (30). Solid medium plates were made 
with the same components of liquid medium plus 2% agar
(Fisher). To express galactose-inducible proteins, 2% raffinose
(Affymetrix, Cleveland, OH) and 2% galactose (Affymetrix)
were used to replace glucose. Fractions of culture were obtained
at designated times to monitor the cell fitness and protein levels
by A600 and immunoblotting, respectively.
All of the yeast strains were grown at 30 °C in 2% glucose
minimal medium overnight. Strains were diluted to A600 of 0.2 
and grown in minimal medium switching the carbon source 
with 2% raffinose for the overnight period. Cultures were nor-
malized to A600 of 0.8, and 5-fold serial dilutions were aliquoted 
onto the respected appropriate dropout plate containing 2% 
glucose or galactose. Plates were incubated at 30 °C for 2–3 
days. 
Yeast Strain Construction 
Yeast strains used in this study are listed in Table 1. The 
hsp31 and atg8 deletions were generated in W303-1A or in a 
strain expressing one or two copies Syn fused to fluorescent
proteins (CFP and YFP) using the primers listed in Table 2. The 
nat (nourseothricin N-acetyltransferase) gene flanked by
Hsp31 homology regions was obtained by PCR with 70-nucle-
otide-long forward primer and reverse primer. The primers 
consisted of 20 nucleotides for amplifying the nat gene from 
pFA6a-natNT2 (Euroscarf) and 50 nucleotides immediately 
preceding the HSP31 or ATG8 start codon or after the stop
codon. The amplified product was integrated into W303 Syn-
expressing strains at ChrIV:1502160 to 1501447, as described 
previously (31). For double knock-out hsp31 atg8 strain, the 
kanMX4 resistance cassette was used to delete Hsp31, and then
the natMX4 resistance cassette was used for deletion of ATG8. 
Hsp31–9myc Tagging 
We endogenously tagged HSP31 with the 9myc epitope using
a PCR-based integration (12). The pYM20 plasmid was used as
a template, and primers were used to obtain PCR product with
HSP31 genomic flanking followed by transformation into 
W303 and W303 Syn-CFP  Syn-YFP strains. The transfor-
mants were selected on media containing hygromycin B (300 
mg/liter), and correct integration was verified by PCR using 
primers spanning the integration junctions and by DNA 
sequence analysis. 
DNA Manipulation 
The plasmids used in this study are listed in Table 3. Plasmid
BG1805 was linearized with NdeI (New England Biolabs, Ips-
wich, MA) and cloned into pDONR221 (Invitrogen) with BP
Clonase (Invitrogen) with the method provided by the manu-
facturer. Hsp31 was shuttled into pAG415-GPD-ccdB-DsRed 
TABLE 2 
Primers 
Gene/Description Forward Reverse 
HSP31 deletion AAGTACTTCCCACTGGCTAATTACACAGATAAAACTCAAACAAA CTTACATCTATATAGTAGTACAAAGGAAATTCTAATTATC 
TTTATAATGACATGGAGGCCCAGAATACCC AACCTTTGGCTCACAGTATAGCGACCAGCATTCAC 
9myc tag of HSP31 TCTGCGCACTCCACTGCCGTAAGATCCATCGACGCTTTAAAAA TCCTTACATCTATATAGTAGTACAAAGGAAATTCTAATTAT 
ACCGTACGCTGCAGGTCGAC CAACCTTTGGCTCAATCGATGAATTCGAGCTCG 
HSP31 AAACTCGAGATGGCCCCAAAAAAAGTTTTACTCGC TTTGCTAGCTCAGTTTTTTAAAGCGTCGATGGATCTTAC 
ATG8 deletion AGTTGAGAAAATCATAATAAAATAATTACTAGAGACATGACAT CGATTTTAGATGTTAACGCTTCATTTCTTTTCATATAAAA 
GGAGGCCCAGAATACCC GACTACAGTATAGCGACCAGCATTCAC 
HSP31 mutation C138D GTTGATCACGGTCCTGCTATTTTTGATGGG GTGATCAACAGCTGCGACAACACCACCG 
ATG8 deletion diagnostic GGGAACCATTAAAGGTTGAGGAGG GTAAACATTCTTATACTGGAACA 
HSP31 9myc tag diagnostic ACAGAGAATTAACGTTACTCATTCC ATATTTGGATATTGGGGAAACACAT 
HSP31 deletion diagnostic TTCGTGGTCGTCTCGTACTC GCAGGGCATGCTCATGTAGA 
TABLE 3 
Plasmids 
Plasmids Type of plasmid Source/Reference 
BG1805 HSP31-MORF Yeast, 2  Gelperin et al. (77) 
pGEX6P-1 HSP31 E. coli This study 
pESC-Leu Yeast, 2  Agilent Technologies 
pESC-Leu myc-HSP31 Yeast, 2  This study 
pNT-hchA His6-hchA E. coli Sastry et al. (78) 
pT7 Syn E. coli Paleologou et al. (33) 
pAG415-GPD HSP31-DsRed-  Yeast, CEN This study 
pAG415-ccdB-DsRed Yeast, CEN Alberti et al. (39) 
pAG424-GAL-PrD-Sup35-EYFP Yeast, 2  Alberti et al. (79) 
p2HG-GPD HSP104-  Yeast J-C. Rochet 
p2HG-GPD Yeast J-C. Rochet 
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(Addgene, Cambridge, MA) (32) from pDONR221 with LR 
Clonase (Invitrogen) to produce pAG415-GPD-HSP31-DsRed. 
Both DJ-1 and Hsp31 were cloned into BamHI/XhoI sites of 
pGEX 6p-1. pESC-Leu myc-HSP31 was constructed by cloning 
at the XhoI/NheI sites. The HSP31 gene was amplified from
yeast genomic DNA. The Hsp31 C138D mutant was prepared 
by PCR amplification using pAG415-GPD-HSP31-DsRed as 
template and the set of primers listed in Table 2. Each success-
fully mutated insert was sequenced to confirm the mutation. 
Antibodies and Immunoblotting 
To determine protein expression, yeast cells were collected 
by centrifuging at 5,000 rpm, and pellets were resuspended in 
extraction buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 4 mM 
MgCl2, 5 mM DTT). Glass beads (Sigma) were added into the 
mixture, which was vortexed 5 times for 10 s each, plus 1-min 
intervals on ice. Clear crude protein lysate was obtained by 
spinning down the cell debris at 1,000  g at 4 °C for 10 min. 
The SDS-PAGE loading dye (4% SDS, 40% glycerol, 0.02% bro-
mphenol blue, Tris-Cl, pH 6.8) was added to the supernatant,
and samples were boiled, followed by SDS-PAGE and immuno-
blotting with antibodies. Monoclonal anti-Myc and anti--ac-
tin antibody were purchased from Sigma-Aldrich. Monoclonal
anti-Syn was obtained from BD Biosciences. Antibodies were
used to detect expression of Hsp104 (ab69549, Abcam), Hsp70
(SPA-82, Stressgen); DsRed (Sc-33353, Santa Cruz Biotechnol-
ogy, Inc.), and GFP (anti-GFP, Roche Applied Science). 
Protein Purification 
BY4741 harboring yeast Hsp31 expression plasmid from the
yeast moveable ORF collection (33) (Thermo Fisher Scientific)
was used to express and purify the protein (33). We did not see
any evidence of co-purifying proteins on SDS-polyacrylamide
gels and observed similar high activity from protein purified 
under high salt conditions, which minimizes contaminant co-
purifying proteins. Human DJ-1 was encoded in pGEX 6p-1 
(GE Healthcare), hchA was encoded in pNT-hchA, and Syn 
was expressed from the pT7 plasmid. The protein expression 
and purification was described previously (34 –36). Briefly,
constructs were transformed into BL21 (DE3) cells. The trans-
formants were grown to an A600 of 0.4 – 0.6 in LB medium sup-
plemented with 100 g/ml ampicillin at 37 °C, and isopropyl 
-D-1-thiogalactopyranoside (1 mM final concentration) was 
added to induce protein expression. After 3 h of induction  at
37 °C, cells were harvested by centrifugation at 2,000  g and 
resuspended in lysis buffer (25 mM KPi, pH 7.0, 200 mM KCl) 
containing protease inhibitor mixture set IV (Calbiochem). 
Crude protein was prepared by sonicating cells and clarifying
the lysate by centrifugation at 10,000  g for 10 min. GST-
tagged DJ-1 was immobilized by glutathione-agarose resin 
(Thermo Scientific), and DJ-1 was eluted by cleaving from the
GST tag with PreScission Protease (GE Healthcare) (2 units of
protease for every 100 g of tagged DJ-1), leaving a linker 
amino acid sequence: NPAFLYKVVDVSRHHHGRIFYPY-
DVPDYAGLEVLFQ. 
Sedimentation velocity ultracentrifugation was performed 
with two different Hsp31 concentrations (34 and 17 M) and
run at 50,000 rpm in a Beckman Coulter XLA centrifuge (Beck-
man Coulter, Fullerton, CA). The sedimentation coefficients
and apparent molecular weights were calculated from size dis-
tribution analyses (c(s)) using SEDFIT (37). 
His -hchA was immobilized by HIS-Select  6 nickel affinity
gel (Sigma-Aldrich) and eluted with elution buffer (Tris-Cl, pH
7.5, 250 M imidazole). The purity of proteins was determined
by SDS-PAGE followed by Coomassie Blue staining, and con-
centrations were determined by a Micro BCA protein assay kit
(Thermo Scientific, Waltham MA). The Syn protein for in 
vitro fibrillization assays was purified by expressing pT7-7 plas-
mid containing human Syn cDNA (provided by R. Jakes and
M. Goedert, Medical Research Council, Cambridge, UK) with
isopropyl -D-1-thiogalactopyranoside in BL21 (DE3) for 4 h of
incubation at 37 °C. The cells were harvested and resuspended
in 10 mM Tris-Cl, pH 8, 1 mM EDTA, 1 mM PMSF at 1⁄ 20 culture 
volume. The cell lysate was obtained by one round of freeze-
thawing and French press treatment, and protein was partially
purified and enriched by two rounds of ammonium sulfate pre-
cipitation (30% saturation first and then 50% saturation at 0 °C).
The pellets were resuspended and boiled in 10 mM Tris-HCl, 
pH 7.4, for 5 min. The insoluble protein was removed by cen-
trifugation, and the supernatant was filtered using a 0.22-m 
filter. The filtered fraction of the protein was applied to a and 2% galactose (induced expression) with 5-fold serial dilu-
DEAE-Sepharose FF column (GE Healthcare) with 10 mM Tris- tions. The plates were incubated at 30 °C for 3 days. 
HCl, pH 7.4, and eluted with 0 –500 mM NaCl over 100 min. 
The fractions containing Syn were dialyzed against 10 m  Fluorescence Imaging of Syn           LocalizationM
NH HCO  and lyophilized. The protein was     4 3 95% pure based pESC-Leu myc-Hsp31 and control empty vector were trans-
on Coomassie Blue staining with SDS-PAGE. formed into two copies of Syn-expressing strain. The Syn
expression was induced by growing cells in synthetic minimum
Chaperone Activity Aggregation Suppression Assays medium plus 2% raffinose and 2% galactose for 8 h. The live
        Thermal Aggregation Assay of    cells were visualized using a Nikon TE2000-U inverted fluores-Citrate Synthase (CS)—CS
 cence  microscope       apochromat   with Nikon Plan 60 (numeri-aggregation suppression assay was performed according to the
        cal aperture 1.4) oil immersion objective and YFP filters plus procedures described previously (38). Briefly, CS (porcine CS,
Sigma), Hsp31, DJ-1, and hchA were buffer-exchanged into 40    300  the localization     magnification.   In   to  order differentiate of
protein, 50 individual      mM Hepes-KOH (pH 7.5). cellsProteins were diluted to were randomly counted in multi-concentra-
           tions ple regions of interest for each set of experiments. The ratio ofranging from 0.1 to 0.6 M in a 500-l reaction. Samples 
     were loaded into a quartz cuvette and placed       membrane ofinto the to cytoplasmic localization Syn fluorescentFluoro-
fusion protein was presented as the mean from  Max-3 spectrofluorometer (Horiba, John Yobin) three indepen-heated to 
       dent sets    of experiments. 43 °C. Aggregation of CS, with and without Hsp31, was mea-
sured by light scattering with the excitation and emission set to MGO Addition and Microscopy 
360 nm and a slit width of 2 nm. BSA fraction V and hchA 
Syn-expressing   strains with or        without the HSP31 gene served as negative and positive controls. Measurements were
deleted were grown   intaken every second for 2,000 s. Data were plotted liquid yeast extract/peptone dextroseusing 
 GraphPad Prism version medium and transferred into medium containing 2% galactose5.0.
  and MGO (0.5–2 m ) for 6 and 12 h. Cells were washed and Reducing Agent-induced Aggregation of Insulin (38, M 39)—
         Briefly, Hsp31 was buffer-exchanged into microscopy to observePBS (pH  subjected to confocal Syn foci forma-7.2). Insulin
           was diluted with PBS  tion.to  presence of26  The MGO inhibited the growth of cells for theM, and 4 or 8  M of Hsp31 was used 
           in a 500-l        initial 12 h and resulted in an equal growth rate between strainsreaction. Samples were loaded into a quartz cuvette regardless of the HSP31 gene deletion. Strains could not be and placed into the FluoroMax-3 spectrofluorometer. Aggre- grown in  
           
the presence of high concentrations of MGO (20 m ), gation of insulin induced by 20 m MM DTT, with and without
              Hsp31, was measured by light scattering with the  so Syn was induced for 10 h, and then MGO was added andexcitation and
    
             
incubated for another 2 h before confocal microscopy analysis. emission set to 360 nm and a slit width of 1 nm. Measurements
were taken every second for 2,000 s. Data were plotted using Assessment of Intracellular ROS 
GraphPad Prism version 5.0. harvested after 
     
Cells 
  
were the induction of Syn expression Spontaneously Fibrillizing Syn Assay—The procedure for for 12 h, and 5  106 cells 
      
were   staining 
  
prepared for with performing the Thioflavin T aggregation assay was described
 were suspended 
          
dihydroethidium. Cells in 250 l of 2.5  g/ml
previously (40). The Syn was prepared by centrifuging the
      
dihydroethidium in PBS and incubated in the dark for 10 min.
recombinant protein through a 100 kDa spin filter to remove   
        
Cells were washed in the PBS and were subjected to fluores-
preformed oligomers (35). DJ-1 and Hsp31 purified from either cence microscopy (excitation at  
 
485 nm and emission at 520 
E. coli or Saccharomyces cerevisiae, respectively, were incu-  and flow 
 
nm) cytometry with the FL-2 channel. FlowJo software
bated with Syn (17.5 M) for 5 days at 37 °C. Thioflavin T (20 was used to calculate median fluorescence intensity. 
M), a fluorescent dye that emits a signal only when binding to 
-sheet-containing protein aggregates, was included in the Prion Expression Experiments 
reaction to detect the fibrillar state of Syn by a Spectrafluor W303 wild type strain was co-transformed with pAG424-
Plus microplate reader (Tecan, Uppsala, Sweden) at 440 nm for GAL-PrD-Sup35-EYFP and pAG415-GPD-HSP31-DsRed. Sin-
the excitation and 490 nm for the emission wavelength. gle transformations were also performed using the same con-
structs and their corresponding control vector. Cells were 
Dilution Growth Assays grown at 30 °C in appropriate medium overnight (SDTrp 
Plasmids (pAG415-GPD-ccdB-DsRed and pAG415-GPD- for pAG424, SDLeu for pAG415, and SDTrpLeu for co-
Hsp31-DsRed) were transformed into W303 Syn-expressing transformants), and protein expression was induced for 24 h in
strains with or without a genomic copy of the HSP31 gene SC 2% raffinose and 2% galactose-containing medium at 30 °C.
knocked out using the PEG/lithium acetate transformation After induction, cells were subjected to fluorescence micros-
method. Single colonies of transformants were grown in copy using a Nikon A1 confocal microscope with a Nikon Plan
SDLeu overnight, and the cells were washed, normalized, apochromat 60 (numerical aperture 1.4) oil immersion objec-
and grown in synthetic complete medium without leucine tive to acquire fluorescence and differential interference con-
(SCLeu)  raffinose (2%) to switch the carbon source. After trast images and were analyzed using ImageJ. Cultures identical
incubating in the raffinose medium overnight, the cell number to those used in microscopy were used to prepare samples for
was normalized, and dilutions were aliquoted on an SDLeu flow cytometry, and cells were washed and resuspended in PBS
(suppressed expression) plate and SCLeu with 2% raffinose at a density of 10  106 cells/ml. Cells were filtered and ana-
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lyzed for EYFP fluorescence intensity using a flow cytometer mphenol blue). The samples were incubated at room tempera-
with the FL-1 channel. A total of 10,000 events were acquired ture for 15 min and loaded onto a 1.8% agarose gel containing 
for each sample, and data were analyzed using FlowJo software 1 TAE and 0.1% SDS and run at 50 V, followed by transfer 
to calculate median fluorescence intensity after three biological onto nitrocellulose membrane using the capillary transfer 
replicates. method. The nitrocellulose membrane was subjected to West-
ern blot analysis using anti-GFP antibody (Roche Applied Sci-
Glutathione-independent Glyoxalase Biochemical Assay ence). A strain harboring p2HG-Hsp104 plasmid was included
Purified recombinant Hsp31 and Hsp31 C138D with the as a positive control. 
GST tag removed were used to assay methylglyoxalase activi-
ties. Results  The reaction was initiated by adding the specified concen-
tration of proteins (1 M Hsp31 and 5 M Hsp31C138D) in Hsp31 Has Chaperone Activity—The S. cerevisiae open read-
reaction buffer (100 mM HEPES, pH 7.5, 50 mM KCl, 2 mM ing frame (YDR533C) has been assigned the name HSP31; how-
DTT) to a 6 mM initial concentration of MGO (Sigma; 40% ever, direct functional studies demonstrating chaperone activ-
solution), followed by incubation at 30 °C. The assay was per- ity have not been conducted on this protein to support its 
formed by removing 50-l aliquots of the reaction at fixed time designation within the HSP family. Hsp31, human DJ-1, and
points (15, 30, 45, and 120 s) after the addition of protein. The hchA are members of the ThiJ/DJ-1 superfamily based on sim-
amount of D-lactic acid produced by Hsp31 as a result of MGO ilarity in structure, so we directly compared the in vitro chap-
consumption was measured. The initial rate obtained was erone activity between these proteins. The influence of Hsp31 
divided by the amount of protein in the reaction mixture to on the aggregation of substrate proteins was measured using
calculate the specific activity. Samples were also subjected to three different model substrates: CS, insulin, and Syn. CS has 
gas chromatography-mass spectroscopy analysis (Agilent been used as a classical substrate for in vitro chaperone assays,
5975C MSD) to identify the presence of D-lactic acid. Samples and both DJ-1 and hchA have demonstrated an ability to sup-
were derivatized with N,O-bis(trimethylsilyl) trifluoroacet- press CS aggregation (9, 43). To assess the chaperone activity of
amide) and trimethylchlorosilane and heated to 50 ºC for 10 Hsp31, we purified the protein from yeast using the BG1805
min and run in the electron impact mode with scanning from plasmid-based system from the yeast movable ORF (MORF)
42 to 400 atomic mass units. A lactic acid standard displayed a collection (33). The C terminus of the protein retains a 4.8-kDa 
peak at 6.09 min identical to the peak detected in the Hsp31- tag, as confirmed by mass spectrometry, and includes a His6 
treated sample, whereas Hsp31C138D did not display this peak. and HA tag (see the amino acid sequence under “Experimental
The spectral scan was visualized and displayed using the Procedures”). We also expressed Hsp31 with a GST tag fused to
OpenChrom software (41). To obtain the enzymatic parame- its N terminus using the pGEX-6p1 plasmid in E. coli. The tag 
ters, the reaction was initiated as described above by adding 1 was removed by 3C protease, and only 3 amino acids (GPL) 
M Hsp31 or 5 M Hsp31C138D protein into reaction buffer, were retained on the recombinant Hsp31 protein, which was 
and reactions were stopped after 1 min by heating at 85 °C for confirmed by mass spectrometry (data not shown). We deter-
30 s. A range of MGO substrate from 50 M to 2 mM and the mined that the purified proteins were folded correctly because
EnzyFluo D-lactate assay kit (Bioassay Systems) were used to they behaved as homodimers based on gel filtration chroma-
determine the amount of D-lactic acid produced in each reac- tography (data not shown) and by analytical ultracentrifugation
tion. Each rate was determined in triplicate, and mean values with a sedimentation coefficient of 3.7 S (Fig. 1A). The Hsp31-
were plotted to obtain enzymatic parameters (V  and K ) by MORF, purified from yeast,   max m can completely suppress the heat-
fitting to a Michaelis-Menten model using GraphPad Prism. induced aggregation of CS when present at a 1:1 molar ratio 
(Fig. 1B). BSA, which was added at a 6-fold molar excess con-
Semidenaturing Detergent-Agarose Gel Electrophoresis centration of CS, had a slight effect on suppressing CS aggrega-
(SDD-AGE) tion in agreement with a previous study that reported BSA as 
W303 cells harboring pAG424-GAL-cPrDSup35-EYFP and having a mild chaperone effect in the CS aggregation assay (44).
pAG415-GPD-HSP31-DsRed plasmids were used, and aggre- E. coli hchA suppressed CS aggregation in a dose-dependent 
gates were produced by inducing for 24 h in SC 2% raffinose  manner, but the high concentration of 0.6 M did not approach 
2% galactose medium. Prion aggregates were analyzed using the considerably more efficient suppression of CS aggregation
SDD-AGE (42). Briefly, to prepare lysates, cells were harvested by Hsp31-MORF (Fig. 1B). In addition, recombinant yeast 
by centrifugation at 3,000  g for 2 min and resuspended in Hsp31 purified from E. coli did not have activity at a 1:1 molar
spheroplast solution (1.2 M D-sorbitol, 0.5 mM MgCl , 20 mM ratio and was needed at high molar ratios similar to hchA 2 (data
Tris (pH 7.5), 50 mM -mercaptoethanol, and 0.5 mg/ml not shown) (Fig. 1B). In conclusion, Hsp31 purified from yeast
Zymolyase) and incubated at 30 °C for 30 min with shaking. can suppress CS aggregation at a 1:1 molar ratio, whereas hchA
After spheroplast formation, the samples were centrifuged at is needed at a 6:1 molar ratio to generate an appreciable sup-
800 rpm for 5 min at room temperature, and supernatant was pression of aggregation. These results are consistent with pre-
removed. The pelleted spheroplasts were resuspended into 100 vious studies, where high molar ratios of hchA were required in
l of lysis buffer (100 mM Tris, pH 7.5, 50 mM NaCl, 10 mM CS assays (38, 45).
-mercaptoethanol, and protease inhibitor) and vortexed at To further characterize the chaperone activity of Hsp31,
high speed for 2 min. The lysates were collected and mixed with additional protein substrates were studied. Hsp31-MORF sup-
4 sample buffer (2 TAE, 20% glycerol, 4% SDS, 0.01% bro- pressed insulin aggregation induced by reducing agent, when 
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FIGURE 1. Hsp31 inhibits in vitro protein aggregation of a variety of substrates. A, the predominant form of Hsp31 is a homodimer in solution. Hsp31 was 
purified from the pGEX E. coli expression plasmid, and the GST tag was proteolytically removed. Sedimentation velocity was performed, and the c(s) distribu-
tion plot demonstrated that the majority species at 3.7 S is a dimeric protein. B, Hsp31 inhibited CS aggregation. CS at 0.1 M reached a maximum aggregation 
(100%) after 30 min of incubation at 43 °C (red). The presence of Hsp31 purified using the MORF yeast expression plasmid suppressed CS aggregation (blue), but 
recombinant Hsp31, purified from the pGEX E. coli expression plasmid (green) with the GST tag removed, had a reduced effect. E. coli hchA was used as a positive 
control (0.2 M (pink) and 0.6 M (purple)) and had less anti-aggregation effect when compared with Hsp31-MORF. BSA, a negative control, had a slight 
anti-aggregation effect but was used at higher protein concentrations (black). Each curve is the average of three independent experiments. C, Hsp31 sup-
pressed aggregation of insulin induced by reducing agent. The amount of 26 M insulin aggregation after a 30-min incubation with 20 mM DTT was used to set 
the 100% aggregation arbitrary units (A.U.) (●). The presence of Hsp31 suppressed insulin aggregation (4 M (f) and 8 M (Œ)). D, Hsp31 suppressed Syn 
fibrillization. Syn alone (●) was considered to be 100% aggregated after 100 h of incubation. Inhibition of Syn fibrillization by Hsp31 was dose-dependent 
(2 M (Œ), 1 M (  ), and 0.5 M ()). DJ-1 (5 M) (f) was used as the positive control in the assay. These data are representative of more than five independent 
experiments with all experiments demonstrating similar trends. 
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using a 3– 6-fold molar excess of insulin (Fig. 1C), further estab-
lishing its chaperone activity in another commonly used chap-
erone assay. The mechanism of Syn aggregation is unclear, 
and DJ-1 has been reported to decrease Syn aggregates or 
cytoplasmic foci in vitro and in vivo (9, 14, 46, 47). Hsp31 com-
pletely suppressed Syn fibrillization despite the presence of an
8-fold molar excess of Syn and maintained chaperone activity 
when Syn was present at a 35:1 molar ratio (Fig. 1D). In agree-
ment with this result, we observed that DJ-1 suppressed Syn
fibrillization although not to the same extent as Hsp31. The
difference may be due to the oxidation state of DJ-1, which has
been shown to affect its activity (46). Taken together, these 
results demonstrate that Hsp31 has the ability to act as a chap-
erone in preventing several types of protein aggregation at substoi-
chiometric concentrations. 
Hsp31 Protects against Syn Toxicity and Reduces Syn Foci 
Formation and ROS Levels—Outeiro and Lindquist (23) dem-
onstrated that two genomic copies of GAL-Syn in yeast
decreased cellular fitness, which was correlated with Syn cel-
lular aggregates (46). DJ-1 has been reported to alleviate protein 
aggregation (9, 46), and Syn has been implicated as a factor in
the progression of PD (48 –50). To determine the chaperone
effect of Hsp31 with its anti-aggregation activity and effect on 
cellular fitness, we tested the rescue of yeast cells from Syn-
mediated toxicity in dilution growth assays. Overexpression of
one copy of the Syn gene from the GAL (galactose) promoter
had negligible effects on cellular fitness, but GAL-driven over-
expression of two Syn gene copies resulted in severe toxicity,
confirming previous findings of dose-dependent toxicity. The 
Syn toxicity was markedly alleviated in the presence of consti-
tutive expression of Hsp31 (pGPD-HSP31), as evidenced by the 
full rescue of cell viability (Fig. 2A). In addition, we expressed 
one copy of GAL-Syn in an hsp31 strain to determine 
whether there was a synthetic genetic interaction between 
these genes. Dilution growth assays demonstrated that expres-
sion of a single copy of Syn or knocking-out HSP31 alone was 
phenotypically similar to the wild-type strain with respect to 
viability. However, cellular fitness was significantly reduced 
when expressing a single copy of Syn in the hsp31 strain (Fig. 
2B). The synthetic lethal interaction of Syn and deleted HSP31 
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FIGURE 2. Hsp31 rescues cells from Syn mediated toxicity. A, Hsp31 co-
expression in yeast reduced Syn toxicity. A yeast strain containing one or 
two copies of genomically expressed GAL-Syn was used in a growth dilution 
assay, in the presence of pGPD-HSP31-DsRed or empty vector, in media con-
taining galactose/raffinose (left) or glucose (right). The strain harboring two 
copies of the Syn gene had better fitness when transformed with the Hsp31-
encoding construct compared with the empty vector. B, combination of 
hsp31 with single copy Syn expression is toxic for yeast. The expression of 
a single copy of Syn in hsp31 strain reduced cellular fitness in the presence 
of glucose (top) and raffinose/galactose (bottom). The overexpression of 
Hsp31 in the same strain was able to rescue viability on both types of media. 
using this approach provided further evidence that Hsp31 is a 
molecular chaperone with the ability to protect cells from 
Syn-mediated toxicity.
Previous studies demonstrated that the subcellular localiza-
tion of Syn changed from the plasma membrane to cytoplas-
mic foci with increased expression of Syn in yeast cells (23). 
Using this relocalization property, we examined the effect of 
pGAL HSP31 overexpression in altering the distinctive subcel-
lular localization profile of 2xGAL-Syn. The same strains used
in the dilution growth assay were used to monitor the effect of
Hsp31 expression on Syn localization. We quantified the 
number of cells with specific localization profiles at 8 h postin-
duction and observed that 60% of cells exhibited Syn foci 
when only expressing Syn, but only 33% of cells co-expressing 
Syn and Hsp31 contained foci (Fig. 3, A and B). We observed 
that the suppression of Syn foci by pGAL HSP31 was transient 
because 24 h after induction, the percentage of cells with foci
increased and was similar to the percentage observed for cells 
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expressing Syn alone. This result is consistent with our rescue
experiments, which were only successful when HSP31 was 
expressed from the GPD promoter (Fig. 2, A and B) and not 
when expressed from the GAL promoter (data not shown). 
The expression of Syn has been demonstrated to increase
the level of ROS in yeast (51). The in vivo suppression of Syn 
foci by Hsp31 and increased toxicity of one copy Syn in the 
hsp31 strain prompted us to investigate the level of ROS in
these different genetic contexts. We found that wild-type yeast
did not have detectable superoxide radicals when treated with
dihydroethidium using microscopy and a fluorescence level of 
0.5 arbitrary units by flow cytometry (Fig. 3, C and D). ROS 
levels were detectable in a fraction of cells in the hsp31 strain 
(6 arbitrary units), indicating that the presence of Hsp31 in the
cell can decrease ROS levels of normal cells not expressing 
Syn. The remaining strains had increased ROS levels in the
following order: Syn-YFP strain (23 arbitrary units), Syn-
YFP hsp31 (41 arbitrary units), Syn-YFP Syn-CFP (64 arbi-
trary units), and Syn-YFP Syn-CFP hsp31 (133 arbitrary 
units). The latter three strains with the highest ROS levels 
exhibit reduced viability when Syn is expressed and form 
increased foci, demonstrating a correlation between these 
phenotypes.
Hsp31 Is an Integral Part of the Yeast Cellular Stress 
Response—Multiple studies have shown that environmental 
stresses, such as oxidative stress and increasing temperature,
increase the expression of Hsp31 (26, 52). A recent study dem-
onstrated increased HSP31 mRNA levels upon treatment with 
H O , during the diauxic shift growth phase  2 2 and stationary 
phase (22). However, the Hsp31 protein level was not charac-
terized under these conditions. We generated a yeast strain 
with a genomically integrated 9myc epitope at the C terminus 
of the HSP31 locus to quantify protein expression. We exam-
ined Hsp31 protein expression levels during growth in rich 
media relative to optical density and demonstrated that Hsp31
expression could be divided into three phases. We found that
Hsp31 expression decreased during log phase and then reached
maximum expression during early stationary phase relative to
the cell density of the culture and remained at approximately
the same level in stationary phase when cell density was sat-
urated after growth for 24 h (Fig. 4A). This distinctive 
expression pattern results in the initiation of elevated 
expression of Hsp31 corresponding to the diauxic shift, which 
occurs between log phase and stationary phase (26). To assess 
whether Hsp31 expression increases under other stress con-
ditions, we exposed cells to H2O2 and observed increased 
protein expression within 1 h of exposure  (Fig. 4B). This 
increased expression in response to an ROS-inducing agent has
been observed previously (22, 26).
We also examined the expression profile of Hsp31 to a pro-
teotoxic stress in the form of Syn overexpression, and the 
results indicated that increased expression of Syn decreases 
cell viability and concomitantly increases the expression of 
Hsp31 during log phase compared with a strain not expressing 
Syn (Fig. 4, C– E). The characteristic decrease in expression
during log phase, 6 –9 h postinoculation, is not observed when 
Syn is expressed. Our data demonstrate that Hsp31 expres-
sion is rapidly elevated at the protein level in the event of 
FIGURE 3. Hsp31 alters the subcellular localization of Syn and decreases ROS generated by Syn. A, single copy of CFP-tagged Syn localized mainly to 
plasma membrane (top left). Cytoplasmic foci predominate when two copies of Syn are expressed (top right). Co-expression of pGAL-HSP31 with GAL-Syn did 
not change the localization of Syn when one copy of the gene was expressed (bottom left) but significantly reduced foci formation when two copies of Syn 
were expressed (bottom right). B, quantification of microscopic images demonstrates that Hsp31 alters the subcellular localization of Syn. The percentage of 
cells with Syn localizing to the membrane when Hsp31 is present is greater in Syn-expressing cells transformed with the Hsp31-encoding construct versus 
the control vector. This experiment was done at 8 h postinduction, and cells with one or more foci were counted in a blinded manner (n  100 cells/sample; **, 
p  0.01 determined by t test; p  0.0013). The column bars represent the means of the three independent biological replicates. Error bars, S.D. C, superoxide 
ions increase when HSP31 is deleted and when Syn is expressed. The in vivo presence of superoxide ions was detected by treatment with dihydroethidium and 
visualization by fluorescence microscopy. Representative fields of view are presented. D, quantification of superoxide ion increase in hsp31- and GAL-Syn-
expressing strains. Flow cytometry was performed on three biological replicates. ****, p  0.0001 based on one-way analysis of variance with multiple 
comparison t test. A.U., arbitrary units. Error bars, S.D. 
growth stress associated with diauxic shift, oxidative stress, and served Glu-Cys-His catalytic triad (18). The first two residues of
proteotoxicity. this triad are critical for MGO activity of DJ-1 as well as Hsp31
Hsp31 Methylglyoxalase Activity Is Not Required for Rescue of in Schizosaccharomyces pombe (54). We determined the meth-
Syn-mediated Toxicity—Recent studies have shown that DJ-1 ylglyoxalase activity for recombinant Hsp31 (purified from 
and Hsp31 are methylglyoxalases that convert MGO into D-lac- E. coli with the GST tag removed to retain 3 amino acids, GPL,
tate in a single step independent of GSH (53, 54). Hsp31, like on the C terminus) and a catalytic triad mutant, Hsp31 C138D,
other members of the DJ-1 superfamily, possesses the con- using a commercially available D-lactate assay kit. As expected, 
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FIGURE 4. Hsp31 expression increases at early stationary phase, under oxidizing conditions, and with Syn expression. A, Hsp31 reached maximal 
expression at early stationary phase. Cell growth curves are represented by A600 values (f). Cells were normalized to A600  0.2 at the start, and aliquots were 
collected until stationary phase was reached 12 h postinoculation and at 24 h when the culture was saturated. The expression of genomically tagged 
Hsp31-9myc expression was assessed via immunoblot analysis of cell lysates obtained at corresponding time points. The plot shows expression levels 
normalized to -actin levels (●). B, H2O2 treatment increases the expression of Hsp31. The Hsp31–9myc strain was exposed to 1 mM H2O2 treatment for 30 and 
60 min, and increased Hsp31 expression was determined by immunoblot. Samples were normalized for cellular density by A600, and -actin was used as a 
loading control. These data are representative of three independent experiments. C, growth curves showing the inhibitory effect of GAL-Syn expression in 
yeast harboring two copies of Syn. Cells were normalized to A600  0.2 at hour 0, representing the time of inoculation, and the OD was monitored for 24 h at 
the identical time points used in A. Cells containing two copies of genomically integrated Syn (f) grew more slowly 9 h after inoculation compared with the 
same strain without Syn (●). D, Hsp31–9myc expression increased in the presence of induced GAL-Syn. The immunoblot was probed with anti-Myc and 
anti--actin antibodies. The level of Hsp31 at the 7.5 and 9 h time points did not decrease in the 2xSyn strain compared with the strain that did not express 
Syn. E, quantitation of Hsp31 expression level reveals increased expression during log phase. The Hsp31–9myc-tagged cells with and without two copies of 
Syn were harvested at 0, 3, 4, 5, 6, 7.5, 9, 12, and 24 h after inoculation. The levels of Hsp31 expression were quantified and normalized to the -actin signal. 
Three independent experiments were performed, and all experiments resulted in similar trends as observed here. A.U., arbitrary units. 
Hsp31 could convert MGO into D-lactate with a calculated spe- using 5 times the amount of protein (detection limit of 0.4 
cific activity of 28.4 mol/min/mg enzyme (using a saturating mol/min/mg). The reaction products of these assays were 
substrate concentration of MGO at 6 mM). These enzymatic examined by GC-MS, and a peak identical to the lactic acid 
parameters indicate a more efficient enzyme activity than the standard (6.09-min elution time) was identified, confirming the
previously reported Hsp31-specific activity of 10.5 D-lactate production of lactic acid by Hsp31 (Fig. 5B). Lactic acid was 
mol/min/mg (53). The Hsp31-MORF purified from yeast had undetectable by GC-MS analysis in the Hsp31 C138D sample
similar enzymatic parameters as the recombinant Hsp31 (data (data not shown).
not shown). Enzymatic parameters were calculated by measur- We next determined whether methylglyoxalase activity is 
ing the time-dependent production of D-lactate with varying required for rescue of Syn toxicity. One copy of Syn-YFP 
substrate concentrations and fitting to a Michaelis-Menten decreases fitness in the hsp31 strain, but GPD-driven expres-
kinetics model, resulting in a V  of 0.0356 mol of D-lactic sion of  max Hsp31 rescues that toxicity. The expression of GPD-
acid/min (S.E.   0.0016), and K    was 247.4 M (S.E.   31.5) driven Hsp31 C138D restored the Syn-expressing strain to m full
(Fig. 5A). Specific activity for the mutant could not be deter- viability comparable with expression of the wild-type Hsp31
mined because low levels of D-lactate were produced despite (Fig. 5C). The lack of enzyme activity for this mutant and the 
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FIGURE 5. Hsp31 is a methylglyoxalase that produces D-lactic acid, and the enzyme activity is not necessary for rescuing Syn toxicity. A, the plot of 
substrate concentration versus rate of D-lactate production by Hsp31 is depicted, and the Michaelis-Menten best fit model is represented by the solid line; Vmax 
and Km were determined based on this model. Mean values of triplicate experiments are plotted. Error bars, S.D. B, GC-MS trace demonstrates a peak (6.09 min) 
consistent with the production of D-lactic acid by Hsp31 in the enzymatic reaction. C, overexpression of pGPD HSP31 or the C138D mutant rescues toxicity from 
Syn-expressing strains. 
ability to rescue Syn toxicity indicated that the in vivo mech- these results is that cell lysates of the hsp31 strain had levels of 
anism of rescue is not dependent on methylglyoxalase activity. overall methylglyoxalase activity equivalent with those of wild
MGO is a toxic metabolite produced during glycolysis (53– type because other yeast methylgloxalase enzymes, Glo1 and
55) that reacts with proteins to yield toxic advanced glycation Glo2, are present in yeast and have been shown to detoxify 
end products (56, 57) and has been associated with increased MGO (59, 60) (data not shown).
Syn cross-linking and formation of intracellular foci forma- Hsp31 and Catalytic Triad Mutants Prevent the Transition 
tion in neuroblastoma cells (58). We examined whether of Syn Monomers to SDS-resistant Oligomeric Species—The 
increased levels of MGO could increase the Syn foci or toxic- demonstrated chaperone activity of Hsp31 prompted us to 
ity by treating cells with exogenous MGO and found no in- investigate at what stage Hsp31 prevents protein aggregation.
creased foci in wild-type yeast, indicating that their formation is We used the spontaneous in vitro fibrillization of Syn assay as 
probably not influenced by MGO. In addition, the hsp31 a method to investigate the different oligomeric species in the
strain also did not have increased foci, suggesting that lack of presence of Hsp31. The prolonged incubation of recombinant
Hsp31 is not sufficient to increase foci formation due to MGO monomeric Syn results in fibrillization and precipitation of
treatment (Fig. 6, A and B). We determined that MGO was toxic the protein. Fractionation of the precipitate versus supernatant 
to wild-type yeast at 10 and 20 mM MGO, and viability in the and subsequent electrophoresis on SDS-PAGE allowed the 
hsp31 strains was similar to wild type, suggesting that Hsp31 detection of different oligomeric species that appear to be SDS-
is not sufficient for detoxification. The concomitant expression resistant (Fig. 7A). The Syn higher order oligomers were 
of Syn (one or two copies) and treatment with MGO did not reduced in the pellet fraction and nearly non-existent in the
have differential effects on viability (Fig. 6C). Consistent with supernatant when Hsp31 wild-type and catalytic triad mutants 
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FIGURE 6. MGO does not increase Syn foci or toxicity. A, representative fluorescence microscopy images of Syn-expressing cells treated with 2 and 20 mM 
MGO. B, the level of Syn foci does not increase with MGO treatment. Percentage of cells with Syn foci formation was quantified for the two strains (Syn-YFP 
and Syn-YFP/Hsp31) in the presence of 2 and 20 mM MGO. Cells in three or more fields of view were counted, and the mean values were plotted (error bars, 
S.D.). Ns, one-way analysis of variance with multiple comparison t test indicates no significant difference. C, MGO treatment does not differentially increase 
toxicity of Syn-expressing strains compared with non-expressing counterparts. Strains were serially diluted on agar plates containing 10 and 20 mM MGO. 
A.U., arbitrary units. 
were present (Fig. 7B). The greatly reduced presence of soluble fluorescent protein tags to prion-forming domains (PrD), so we
but SDS-resistant oligomers indicates that Hsp31 may interact overexpressed Hsp31 to determine whether it modulated the 
with the monomer or an early oligomeric species to prevent aggregation of Sup35 PrD. Consistent with previous findings,
formation of later stage oligomers. The same reactions were cells overexpressing PrD in the presence of endogenous Sup35
monitored using the ThioT assay, and only a baseline level of showed characteristic ribbon-like or punctate aggregates, 
fluorescence was observed in the presence of Hsp31, further which were localized around the vacuoles and/or adjacent to 
supporting the hypothesis that Hsp31 interacts with an Syn plasma membranes (Fig. 8A). The number of cells co-express-
species that precedes larger oligomers detected by ThioT (Fig. ing pGPD-HSP31-DsRed and pGAL-PrD-Sup35-EYFP had 
7C). The ability of mutants to reduce fibrillization is consistent 3-fold fewer Sup35 fluorescent aggregates compared with 
with our observation that the mutants suppress Syn toxicity in cells harboring pGAL-PrD-Sup35-EYFP plus vector control, 
yeast (Fig. 5C). indicating that Hsp31 can inhibit the formation of microscop-
Hsp31 Prevents Formation of Large Prion Aggregates—The ically visible Sup35 prion aggregates (Fig. 8, A and B). The 
demonstration that Hsp31 possesses chaperone activity in a intrinsic fluorescence of Sup35-EYFP appears to increase upon
variety of anti-aggregation assays prompted us to investigate aggregation, which allowed us to utilize flow cytometry as 
whether Hsp31 could also modulate the oligomeric state of an alternative method to quantitatively measure and show 
yeast prion proteins, such as the Sup35 prion. The aggregation decreased Sup35 aggregation (Fig. 8C). This phenomenon has
state of prions in living cells can be monitored by fusion of not been exploited widely but was noted in at least one previous 
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FIGURE 7. Hsp31 and catalytic mutants prevent the formation of Syn oligomers. A, flow chart depicting the fractionation of the Syn fibrillization assay 
and detection of monomeric and oligomeric species. SDS-PAGE of the pellet and supernatant fractions was performed, and antibodies were used to detect 
Syn followed by stripping of the membrane and reprobing with anti-HA tag antibody to detect Hsp31 (note that Hsp31 was purified using the MORF tag, but 
Protein A was removed proteolytically, and the HA tag is retained). B, Hsp31 suppresses the formation of SDS-resistant higher order oligomers detected with 
Western blotting of the pellet and supernatant fractions. C, Hsp31 catalytic triad mutants suppress Syn fibrillization. All proteins were added at the same level 
of 2 M. A.U., arbitrary units. 
study investigating the aggregation of a huntingtin-GFP fusion the area where there was a Sup35 aggregate, suggesting that
protein (61). Cell cultures co-expressing Sup35 and Hsp31 used Hsp31 is not incorporated in aggregates (Fig. 9A). The aggre-
in the microscopy experiments were prepared for flow cytom- gate appears to occlude Hsp31, and the diffuse overlapping
etry and analyzed for EYFP fluorescence intensity. The flow signal observed in some cells is consistent with the presence
cytometry results were similar to the microscopy results of Hsp31 throughout the cytoplasm surrounding the aggre-
because Hsp31-expressing cells consistently exhibited lower gate. We also confirmed that Hsp31 overexpression reduces
median Sup35-EYFP fluorescence intensity when compared the formation of in vivo aggregates based on assessing cell 
with cells containing Sup35-EYFP expression plasmid and lysates by SDD-AGE. We found that SDS-resistant Sup35 
empty vector (Fig. 8C). Individual traces depicting the number aggregates were greatly reduced when Hsp31 was overex-
of counting events for each yeast strain also show the decrease pressed. The positive control, Hsp104, completely elimi-
in cellular fluorescence intensity when Hsp31 is expressed (data nated detectable Sup35 aggregates (Fig. 9B). These results 
not shown). are consistent with the ability of Hsp31 to inhibit the forma-
Expression of Hsp31 with the GPD promoter was diffuse and tion of large protein aggregates.
cytoplasmic and varied in intensity in individual cells across the We also ascertained whether other chaperones are induced 
total cell population. The cytoplasmic localization profile of upon overexpression of Hsp31. We demonstrated that Hsp70
Hsp31 was not altered when PrD-Sup35 was expressed (Fig. and Hsp104 expression are not altered, and hence elevated 
8A). Interestingly, we observed overlapping localization in cells expression of these chaperones is not responsible for the 
with Sup35 aggregates and relatively high levels of Hsp31, but observed suppression of prion aggregates (Fig. 9C). This is in 
the proteins do not appear to mutually co-localize (Fig. 9A). In agreement with our in vitro aggregation studies establishing
some cells, it was evident that the DsRed signal was decreased in that purified and recombinant Hsp31 protein is solely sufficient 
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FIGURE 8. Fluorescence microscopy demonstrating Hsp31 suppression of Sup35 aggregation. A, PrD-Sup35 produced ribbon-like and punctate aggre-
gates that are decreased when Hsp31 is overexpressed. PrD-Sup35-EYFP was overexpressed for 48 h at 30 °C in control W303 cells or W303 cells expressing 
elevated levels of Hsp31. Hsp31 was diffuse in the cytoplasm and decreased the presence of Sup35 aggregates. The diffuse cytoplasmic localization of Hsp31 
did not appear to be altered as a result of Sup35 expression. B, quantitation of cells with one or more Sup35-EYFP foci. A smaller proportion of cells with Sup35 
aggregates was evident in Hsp31-overexpressing cells compared with vector control (pGPD). Values represent mean  S.E. (n  3). ***, two-tailed Student’s t 
test; p  0.001. C, quantitation of Sup35-EYFP fluorescence suppression by Hsp31 using flow cytometry. Hsp31 overexpression lowers the median fluorescence 
intensity (FI; arbitrary units (A.U.)) of Sup35 compared with empty vector control. *, two-tailed Student’s t test; p  0.05). Error bars, S.E.; n   3 biological 
replicates. DIC, differential interference contrast. 
Hsp31 Is a Stress Response Chaperone 













0. 0.. :c + 
+ 
-0 
" ~ ~ 













<8 -~ IO 
£ "' " j .§ 
,r, 






pGPD HSP3I -DsRed pGPD 
pGAL cPrD-EYFP cPrD-EYFP cPrD-EYFP 
+ HSP3/- + pGPD 
DsRed 
§ASBMB 
to prevent protein aggregation, although we cannot exclude the
possibility that Hsp31 could collaborate with other chaperones
to prevent prion aggregation in the cell.
Hsp31 Rescue of Syn-mediated Toxicity Is Independent
of the Autophagy Pathway—Recently, in several studies, 
autophagy has been identified as one of the main mechanisms 
to clear and recycle misfolded proteins and aggregates in the
cytosol (62, 63). In addition to the ubiquitin proteasome system,
autophagy is a major cellular function involved in clearance of
misfolded and aggregated proteins, including Syn aggregates 
(62). Deletion of autophagy genes, such as ATG5 or ATG7, 
leads to neurodegenerative disease in mice (64, 65). In yeast,
deletion of the ATG1 gene reduced the clearance of Syn aggre-
gates (66). Deletion of HSP31 was also demonstrated to impair 
autophagy under carbon starvation conditions (22). These 
studies raise the possibility that Hsp31 could be promoting
autophagy of aggregated protein. In order to exclude the possi-
bility that the Hsp31 rescue effect on Syn toxicity depends on 
autophagy, we deleted the ATG8 gene in the Syn strains and 
assessed the synthetic lethal effects of Syn expression in these 
strains. As expected, expression of Syn in the atg8 strain 
resulted in decreased viability compared with the wild-type
strain. The atg8 hsp31 strain had viability similar to that of 
the atg8 strain when Syn was expressed (Fig. 10A). These 
results confirm that autophagy is a protective mechanism 
against Syn toxicity. The lack of synthetic lethal defect 
between ATG8 and HSP31 with and without Syn expression is 
consistent with genes that are in the same pathway and hence
do not buffer each other. Expression of Hsp31 and the C138D
mutant in the autophagy strains, atg8 Syn or atg8 hsp31 
Syn, increased viability in rich YEP media compared with vec-
tor controls (Fig. 10B). We found that the rescue effect in syn-
thetic media was not easily observed because expression of 
Syn was not toxic in the atg8 strain background, but it was 
toxic in the hsp31, indicating that media conditions are an 
important factor in this complex relationship (Fig. 10B, mid-
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FIGURE 9. Hsp31 and Sup35 are not mutually co-localized, and Hsp104 and Hsp70 are not altered. A, most cells with high levels of expression of Hsp31 and 
Sup35 exhibited diffuse cytoplasmic localization for Hsp31 that overlapped with Sup35 (top). Occlusion of Hsp31 from the Sup35 aggregate was also observed, 
as evidenced by the decreased DsRed signal at aggregate sites (white arrows, bottom panel). B, SDS-resistant Sup35 aggregates are suppressed by Hsp31. 
Cellular lysates were subjected to SDD-AGE and SDS-PAGE. Overexpression of Sup35-PrD-EYFP initiated the formation of Sup35 aggregates, which were 
detected with anti-GFP antibody. C, Hsp31 overexpression does not alter the expression levels of Hsp104 and Hsp70. Cells of the BY4741 strain harboring the 
pGPD-HSP31-DsRed or vector control (pGPD) were grown overnight, and samples were prepared as described in the legend to Fig. 3. Immunoblots (IB) were 
probed with anti-Hsp104, anti-Hsp70, anti-DsRed, and anti-actin antibodies. 
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dle). These results demonstrate that Hsp31 can rescue Syn
toxicity in autophagy-deficient cells. 
Discussion 
The roles of chaperones and proteases in maintaining integ-
rity and activity of folded, partially folded, and misfolded pro-
teins are well established. Members of the DJ-1/ThiJ/PfpI
superfamily exist in prokaryotes and eukaryotes, and structural
and biochemical analyses have established that they have mul-
tiple activities, including chaperone, protease, and enzymatic
functions. Because of the multiple activities associated with this
superfamily, we sought to characterize the chaperone activity of
Hsp31 and delineate its contribution in protecting against cel-
lular stress. 
The crystal structure of yeast Hsp31 has been solved, and
structural evidence shows that Hsp31 and hchA share high sim-
ilarity, in terms of the position of a hydrophobic patch and a 
catalytic triad. Yeast Hsp31, E. coli hchA, and human DJ-1 are 
in the same DJ-1/PfpI/ThiJ superfamily, and the literature sug-
gests that both DJ-1 and hchA have chaperone-like effects 
against protein aggregation. Despite these similarities, the 
structures differ in important details, and it could have been
argued that Hsp31 might not possess chaperone activity based
on the absence of 45 amino acids present in hchA and the dis-
tinct dimerization. We investigated whether the chaperone-
like activities are conserved in Hsp31 and found that the protein
showed broad chaperone activity on three different substrate 
proteins, with aggregation induced by different mechanisms. 
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CS aggregation is triggered by elevated temperature, and we 
demonstrated that Hsp31 suppresses CS aggregation 6-fold 
more efficiently then hchA and DJ-1. Hsp31 also suppresses
insulin aggregation, demonstrating that Hsp31 can maintain 
chaperone activity in a reducing environment in contrast to the
redox-dependent DJ-1, which does not have activity in this 
assay.
Hsp31 also exhibited considerable activity in an in vitro Syn
fibrillization assay and completely suppressed fibrillization at a
molar ratio of 8.75:1 (Syn/Hsp31) and maintained consider-
able activity at a ratio of 35:1. DJ-1 also had activity at substoi-
chiometric levels but required higher molar ratios compared
with Hsp31. We consistently observed that the Hsp31-MORF
purified from yeast was more active than recombinant Hsp31, 
DJ-1, or hchA (Fig. 1, B and D). This could be due to the fusion 
tag type or fusion orientation affecting protein activity, which
has been noted previously for hchA (17, 18). Further studies are
needed to delineate the source of these activity differences, 
including the possibility that it is related to the purification
procedure, oxidation state of the protein, oligomeric state, or 
post-translational modifications. The broad range of substrates
and substoichiometric activity all indicate that Hsp31 is a chap-
erone with robust activity compared with other members of
this superfamily.
Despite the fact that its cellular function is incompletely 
understood, Syn is known to aggregate and form inclusions. 
These protein inclusions are precursors of Lewy bodies, the 
pathological hallmark of PD. Elucidating mechanisms of Syn
aggregation is important to understand PD pathogenesis, and
the heterologous expression of Syn in yeast established a use-
ful platform to investigate Syn biology (9). We extended the 
Syn yeast model by demonstrating the modulation of Syn
toxicity and subcellular localization by Hsp31. Expression of
2xGAL Syn is toxic to yeast cells, and constitutive expression
of Hsp31 from the GPD promoter rescued cells from Syn-
mediated toxicity (Fig. 2). In addition, expression of one copy of
GAL Syn is not toxic to wild-type cells but is toxic in the 
hsp31 strain. Taken together, it appears that the chaperone
effect of Hsp31 is necessary to maintain cellular fitness upon 
Syn expression.
Hsp31 also altered the subcellular localization profile of 
Syn. Expression of 2xGAL Syn results in cytosolic accumu-
lations (foci), whereas the expression of one copy of GAL Syn 
results in primarily plasma membrane localization. The in vivo 
FIGURE 10. The autophagy pathway prevents Syn toxicity but is not required for Hsp31-mediated rescue. A, yeast strains serially diluted on YEP agar 
plates (glucose or raffinose/galactose) demonstrating the toxicity of GAL-Syn in the atg8, hsp31, and atg8 hsp31 strains. B, overexpression of HSP31 
using pAG415-GPD-HSP31-DsRed or the C138D mutant partially rescued toxicity of Syn expression on YEP media for the atg8, hsp31, and atg8 hsp31 
strains (right). Rescue by HSP31 overexpression could not be assessed in synthetic media for strains with the atg8 genotype because GAL-Syn expression was 
not toxic in these strains (middle). Rescue of GAL-Syn expression in the hsp31 strain was toxic and rescued by HSP31 overexpression in synthetic and YEP 
media. 
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cytoplasmic foci are associated with vesicular membranes (39),
and analysis of cellular lysates indicates the presence of higher
order oligomeric forms of Syn, although the nature of this 
aggregation is unclear (23, 67). Expression of GAL-HSP31 
results in more than 2-fold suppression of foci and increases the
localization of Syn to the plasma membrane (Fig. 3A). This
effect was transiently observed at 8 h postinduction, but a high
rate of puncta formation returned after 24 h, possibly because
Hsp31 expression was induced at the same time as Syn. This is 
consistent with the result where GAL-HSP31 does not rescue 
the synthetic lethal effect of Syn expression in the hsp31 
strain, whereas the constitutive GPD-HSP31 rescues hsp31. 
These results indicate that a higher threshold level of Hsp31 is
needed in the cell prior to Syn induction to prevent toxicity. 
The exact temporal relationship between Hsp31 expression 
and Syn foci suppression could provide insight into the aggre-
gation state of Syn species targeted by Hsp31.
Several orthologous experiments suggest that Hsp31 inter-
acts early in the misfolding process and prevents the formation
of larger oligomeric species. The addition of Hsp31 to Syn
monomers in a fibrillization assay resulted in a baseline level of
ThioT fluorescence signal, indicating that the formation of 
larger oligomeric species was prevented (Fig. 1D). Analysis
of the SDS-resistant oligomeric species by SDS-PAGE demon-
strated that the presence of Hsp31 prevented the formation of
higher order oligomeric Syn species (Fig. 7A). Our prion
aggregation studies indicate that Hsp31 inhibits prion assembly
before the formation of subcellular visible GFP-tagged PrD 
aggregates and those detected by SDD-AGE (Fig. 9B). Further-
more, the Sup35 aggregates occlude Hsp31, indicating that the
anti-aggregation activity of Hsp31 commences prior to the for-
mation of the visible aggregate and probably does not act to 
remove or disassemble any preformed aggregate (Fig. 9A). This 
is in contrast to large chaperones, Hsp104, Ssa1/2, Sis1, and
Sse1, which mutually colocalize with prion aggregates (68). A
previous study has demonstrated that small HSPs can inhibit 
the formation of Sup35 aggregates and found that Hsp26 and
Hsp42 inhibit rare transient oligomers at distinctly different 
steps in the prion formation process (69). Further studies will be
required to determine whether Hsp31 inhibits protein misfold-
ing with a similar or distinct mechanism as Hsp26 or Hsp42. 
Overall, we demonstrate that Hsp31 can inhibit oligomeriza-
tion or aggregation of many different proteins by intervening
early in the process.
The role of Hsp31 in protecting cells from Syn-mediated 
toxicity led us to investigate the expression of Hsp31 in 
response to proteotoxic stress and other types of stress. The 
expression pattern of Hsp31 in a genomically tagged strain 
decreased during log phase growth and increased at the diauxic
shift and at saturation (Fig. 4). The increased expression of 
Hsp31 at the diauxic shift and in stationary phase could possibly
be due to the stress of decreased nutrients or accumulation of 
metabolites associated with these growth phases and is part of a
global transcriptional response program (70). An increase in
Hsp31 expression in response to ROS has been observed previ-
ously (71), and we confirmed that our tagged strain behaved in 
a similar manner by demonstrating an increase in expression 
upon exposure to H O  (Fig. 4B). This ROS response has been 2 2
implicated to be dependent on the Yap1 stress response tran-
scription factor, and a shortened Hsp31 promoter (313 bp 
relative to the ATG), which removes the Yap1 binding site 
(363 and 353 bp relative to the ATG), has decreased Hsp31
expression in response to oxidative stress (72). However, we 
note that the shortened promoter also removes an additional 
stress response element (a CCCCT site at 379 to 383 from 
the ATG) in proximity to the Yap1 binding site. Stress response
elements have been demonstrated to be the binding site for 
Msn2/4, and numerous stress-related yeast genes have been 
documented to be transcriptionally activated by these tran-
scription factors (26), including genes up-regulated after the
diauxic shift in stationary phase cells (26). Hsp31 appears to be
part of the global transcriptional stress response by Yap1 and
Msn2/4 or other stress-related transcription factors, such as 
Hsf1 or Gis1. 
Finally, we also examined the response of Hsp31 expression
during Syn-initiated proteotoxic stress and observed an 
increased expression in cells in log phase. We measured an 
increase in superoxide levels upon Syn expression consistent 
with a previous report that indicated that Syn expression is 
associated with caspase-mediated ROS generation (73) (Fig. 
3D). Deletion of HSP31 also leads to increased superoxide levels 
with or without Syn expression. These results establish that 
Hsp31 has a role in response to ROS, and its expression is 
induced in response to several types of stress.
We demonstrated the robust chaperone activity of Hsp31,
but the in vivo rescue effects could have been mediated by the
Hsp31 methylglyoxalase activity or interaction with other bio-
logical pathways, such as the metabolic or autophagy pathway.
We confirmed that Hsp31 does have methylglyoxalase activity
and demonstrated that mutation of the catalytic triad residue,
C138D, results in greatly reduced methylglyoxalase activity 
(Fig. 5, A and B). However, this mutation did not inactivate the
chaperone activity in the Syn fibrillization assay (Fig. 7C), and 
expression of GPD-HSP31 C138D rescued cells from Syn-me-
diated toxicity (Fig. 5C). Furthermore, we showed that that 
exogenous MGO did not differentially affect viability, suggest-
ing that Hsp31 does not rescue by reducing accumulation of 
this toxic metabolite in Syn-expressing cells (Fig. 6). 
We also demonstrated that the autophagy pathway is an 
important mediator in the Syn toxicity because deletion of 
ATG8 resulted in synthetic lethal interaction with Syn expres-
sion (Fig. 10A). This is consistent with atg1 or atg7 strains 
having synthetic lethal interactions with Syn expression and 
having defects in clearing Syn foci (74). However, we show 
that the hsp31 atg8 strain does not have increased Syn-
mediated toxicity when compared with atg8, consistent with 
these genes occurring within the same synthetic lethal pathway.
A recent result indicates that hsp31 strains are defective in 
autophagy (51), so the addition deletion of an autophagy gene 
should not increase toxicity. Interestingly, overexpression of 
Hsp31 in these autophagy-deficient strains can rescue cells 
from Syn toxicity, indicating that the autophagy pathway is
not essential for chaperone rescue (Fig. 10B). Autophagy may 
be beneficial for controlling Syn toxicity, but it appears that
chaperone activity of Hsp31 is also important. These experi-
ments also are the first to delineate that enzymatic methylg-
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lyoxalase activity of Hsp31 is not essential to rescue Syn 
toxicity.
Our results suggest that Hsp31 functions as a cytoplasmic
chaperone against a variety of misfolded proteins. Recent stud-
ies have demonstrated the facility of yeast to investigate patho-
genic mechanisms underlying Syn toxicity, including the 
identification of novel biological pathways that impinge on 
Syn biology and small molecule modulators of Syn toxicity 
(66, 69). In addition, the action of Hsp31 on Syn may provide 
insight into the mode of toxicity of Syn because recent evi-
dence suggests that the Syn toxic species is smaller than the
visible aggregate (66). It should be noted that the prion expres-
sion studies done in this study were not completed with [PSI]
strains, but further studies using such strains would be of inter-
est to determine the effect of Hsp31 on prion initiation and 
propagation.
We have established a framework that extends the yeast 
model for investigating mechanisms of Syn toxicity in the 
context of the DJ-1/ThiJ/PfpI superfamily in yeast. Extension of
this work will assist in elucidation of the chaperone-like mech-
anisms of Hsp31, and a comparison with DJ-1 may provide
evolutionary insights into the activities of the DJ-1/PfpI/ThiJ
superfamily. Our model may also be used to further delineate
the nature of oligomeric species in the pathogenesis of PD 
and possibly what species of Syn should be targeted 
therapeutically. 
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Rosado-Ramos, R., Betzer, C., Straatman, K. R., Jensen, P. H., Giorgini, F., 
and Outeiro, T. F. (2014) DJ-1 interactions with -synuclein attenuate 
aggregation and cellular toxicity in models of Parkinson’s disease. Cell 
Death Dis. 5, e1350 
22. Miller-Fleming, L., Antas, P., Pais, T. F., Smalley, J. L., Giorgini, F., and 
Outeiro, T. F. (2014) Yeast DJ-1 superfamily members are required for 
diauxic-shift reprogramming and cell survival in stationary phase. Proc. 
Natl. Acad. Sci. U.S.A. 111, 7012–7017 
23. Outeiro, T. F., and Lindquist, S. (2003) Yeast cells provide insight into 
-synuclein biology and pathobiology. Science 302, 1772–1775 
24. Willingham, S., Outeiro, T. F., DeVit, M. J., Lindquist, S. L., and 
Muchowski, P. J. (2003) Yeast genes that enhance the toxicity of a mutant 
huntingtin fragment or -synuclein. Science 302, 1769 –1772 
25. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, 
B., Liu, K., Xu, K., Strathearn, K. E., Liu, F., Cao, S., Caldwell, K. A., 
Caldwell, G. A., Marsischky, G., Kolodner, R. D., Labaer, J., Rochet, J. C., 
Bonini, N. M., and Lindquist, S. (2006) -Synuclein blocks ER-Golgi traffic 
and Rab1 rescues neuron loss in Parkinson’s models. Science 313, 
324 –328 
26. Skoneczna, A., Miciałkiewicz, A., and Skoneczny, M. (2007) Saccharomy-
ces cerevisiae Hsp31p, a stress response protein conferring protection 
against reactive oxygen species. Free Radic. Biol. Med. 42, 1409 –1420 
27. Kim, I. S., Sohn, H. Y., and Jin, I. (2011) Adaptive stress response to men-
adione-induced oxidative stress in Saccharomyces cerevisiae KNU5377. J. 
Microbiol. 49, 816 – 823 
28. Takanishi, C. L., and Wood, M. J. (2011) A genetically encoded probe for 
the identification of proteins that form sulfenic acid in response to H2O2 
in Saccharomyces cerevisiae. J. Proteome Res. 10, 2715–2724 
29. de Melo, H. F., Bonini, B. M., Thevelein, J., Simões, D. A., and Morais, 
M. A., Jr. (2010) Physiological and molecular analysis of the stress re-
sponse of Saccharomyces cerevisiae imposed by strong inorganic acid with 
implication to industrial fermentations. J. Appl. Microbiol. 109, 116 –127 
30. Amberg, D., Burke, D., and Strathern, J. (2005) Methods in Yeast Genetics: 
A Cold Spring Harbor Laboratory Course Manual, 2005 Ed., Cold Spring 
Harbor Laboratory Press, Cold Spring Harbor, NY 
31. Janke, C., Magiera, M. M., Rathfelder, N., Taxis, C., Reber, S., Maekawa, 
H., Moreno-Borchart, A., Doenges, G., Schwob, E., Schiebel, E., and Knop, 
M. (2004) A versatile toolbox for PCR-based tagging of yeast genes: new 
fluorescent proteins, more markers and promoter substitution cassettes. 
Yeast 21, 947–962 
32. Alberti, S., Gitler, A. D., and Lindquist, S. (2007) A suite of Gateway 
cloning vectors for high-throughput genetic analysis in Saccharomyces 
cerevisiae. Yeast 24, 913–919 
33. Gelperin, D. M., White, M. A., Wilkinson, M. L., Kon, Y., Kung, L. A., 
Wise, K. J., Lopez-Hoyo, N., Jiang, L., Piccirillo, S., Yu, H., Gerstein, M., 
Dumont, M. E., Phizicky, E. M., Snyder, M., and Grayhack, E. J. (2005) 
Biochemical and genetic analysis of the yeast proteome with a movable 
ORF collection. Genes Dev. 19, 2816 –2826 
34. Conway, K. A., Harper, J. D., and Lansbury, P. T., Jr. (2000) Fibrils formed 
in vitro from -synuclein and two mutant forms linked to Parkinson’s 
disease are typical amyloid. Biochemistry 39, 2552–2563 
35. Rochet, J. C., Conway, K. A., and Lansbury, P. T., Jr. (2000) Inhibition of 
fibrillization and accumulation of prefibrillar oligomers in mixtures of 
human and mouse -synuclein. Biochemistry 39, 10619 –10626 
36. Krasnoslobodtsev, A. V., Peng, J., Asiago, J. M., Hindupur, J., Rochet, J. C., 
and Lyubchenko, Y. L. (2012) Effect of spermidine on misfolding and 
interactions of -synuclein. PLoS One 7, e38099 
37. Brown, P. H., and Schuck, P. (2006) Macromolecular size-and-shape dis-
tributions by sedimentation velocity analytical ultracentrifugation. Bio-
phys. J. 90, 4651– 4661 
38. Sastry, M. S., Korotkov, K., Brodsky, Y., and Baneyx, F. (2002) Hsp31, the 
Escherichia coli yedU gene product, is a molecular chaperone whose ac-
tivity is inhibited by ATP at high temperatures. J. Biol. Chem. 277, 
46026 – 46034 
39. Sastry, M. S., Zhou, W., and Baneyx, F. (2009) Integrity of N- and C-ter-
mini is important for E. coli Hsp31 chaperone activity. Protein Sci. 18, 
1439 –1447 
40. Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T. M., and Subrama-
niam, V. (2002) Dependence of -synuclein aggregate morphology on 
solution conditions. J. Mol. Biol. 322, 383–393 
41. Wenig, P., and Odermatt, J. (2010) OpenChrom: a cross-platform open 
source software for the mass spectrometric analysis of chromatographic 
data. BMC Bioinformatics 11, 405 
42. Halfmann, R., and Lindquist, S. (2008) Screening for amyloid aggregation 
by semi-denaturing detergent-agarose gel electrophoresis. J. Vis. Exp. 17, 
e838 
43. Malki, A., Kern, R., Abdallah, J., and Richarme, G. (2003) Characterization 
of the Escherichia coli YedU protein as a molecular chaperone. Biochem. 
Biophys. Res. Commun. 301, 430 – 436 
44. Marini, I., Moschini, R., Del Corso, A., and Mura, U. (2005) Chaperone-
like features of bovine serum albumin: a comparison with -crystallin. Cell 
Mol. Life Sci. 62, 3092–3099 
45. Choi, D., Ryu, K. S., and Park, C. (2013) Structural alteration of Escherichia 
coli Hsp31 by thermal unfolding increases chaperone activity. Biochim. 
Biophys. Acta 1834, 621– 628 
46. Zhou, W., Zhu, M., Wilson, M. A., Petsko, G. A., and Fink, A. L. (2006) The 
oxidation state of DJ-1 regulates its chaperone activity toward -sy-
nuclein. J. Mol. Biol. 356, 1036 –1048 
47. Zhou, W., and Freed, C. R. (2005) DJ-1 up-regulates glutathione synthesis 
during oxidative stress and inhibits A53T -synuclein toxicity. J. Biol. 
Chem. 280, 43150 – 43158 
48. Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzy-
czka, N., Mandel, R. J., and Björklund, A. (2002) Parkinson-like neurode-
generation induced by targeted overexpression of -synuclein in the ni-
grostriatal system. J. Neurosci. 22, 2780 –2791 
49. Ko, L. W., Ko, H. H., Lin, W. L., Kulathingal, J. G., and Yen, S. H. (2008) 
Aggregates assembled from overexpression of wild-type -synuclein are 
not toxic to human neuronal cells. J. Neuropathol. Exp. Neurol. 67, 
1084 –1096 
50. Lee, H. J., and Lee, S. J. (2002) Characterization of cytoplasmic -synuclein 
aggregates: fibril formation is tightly linked to the inclusion-forming pro-
cess in cells. J. Biol. Chem. 277, 48976 – 48983 
51. Flower, T. R., Chesnokova, L. S., Froelich, C. A., Dixon, C., and Witt, S. N. 
(2005) Heat shock prevents -synuclein-induced apoptosis in a yeast 
model of Parkinson’s disease. J. Mol. Biol. 351, 1081–1100 
52. Miura, T., Minegishi, H., Usami, R., and Abe, F. (2006) Systematic analysis 
of HSP gene expression and effects on cell growth and survival at high 
hydrostatic pressure in Saccharomyces cerevisiae. Extremophiles 10, 
279 –284 
53. Hasim, S., Hussin, N. A., Alomar, F., Bidasee, K. R., Nickerson, K. W., and 
Wilson, M. A. (2014) A glutathione-independent glyoxalase of the DJ-1 
superfamily plays an important role in managing metabolically generated 
methylglyoxal in Candida albicans. J. Biol. Chem. 289, 1662–1674 
54. Zhao, Q., Su, Y., Wang, Z., Chen, C., Wu, T., and Huang, Y. (2014) Iden-
tification of glutathione (GSH)-independent glyoxalase III from Schizos-
accharomyces pombe. BMC Evol. Biol. 14, 86 
55. Lee, J. Y., Song, J., Kwon, K., Jang, S., Kim, C., Baek, K., Kim, J., and Park, C. 
(2012) Human DJ-1 and its homologs are novel glyoxalases. Hum. Mol. 
Genet. 21, 3215–3225 
56. Angeloni, C., Zambonin, L., and Hrelia, S. (2014) Role of methylglyoxal in 
Alzheimer’s disease. Biomed. Res. Int. 2014, 238485 
57. Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., and Aldini, 
G. (2013) Advanced glycoxidation and lipoxidation end products (AGEs 
and ALEs): an overview of their mechanisms of formation. Free. Radic. 
Res. 47, 3–27 
58. Shaikh, S., and Nicholson, L. F. (2008) Advanced glycation end products 
induce in vitro cross-linking of -synuclein and accelerate the process of 
intracellular inclusion body formation. J. Neurosci. Res. 86, 2071–2082 
59. Bito, A., Haider, M., Hadler, I., and Breitenbach, M. (1997) Identification 
and phenotypic analysis of two glyoxalase II encoding genes from Saccha-
romyces cerevisiae, GLO2 and GLO4, and intracellular localization of the 
corresponding proteins. J. Biol. Chem. 272, 21509 –21519 
60. Inoue, Y., and Kimura, A. (1996) Identification of the structural gene 
for glyoxalase I from Saccharomyces cerevisiae. J. Biol. Chem. 271, 
25958 –25965 
61. Kvam, E., Nannenga, B. L., Wang, M. S., Jia, Z., Sierks, M. R., and Messer, 
A. (2009) Conformational targeting of fibrillar polyglutamine proteins in 
live cells escalates aggregation and cytotoxicity. PLoS One 4, e5727 
62. Nixon, R. A. (2013) The role of autophagy in neurodegenerative disease. 
Nat. Med. 19, 983–997 
63. Qi, L., and Zhang, X. D. (2014) Role of chaperone-mediated autophagy in 
degrading Huntington’s disease-associated huntingtin protein. Acta 
Biochim. Biophys. Sin. 46, 83–91 
64. Au, A. K., Bayir, H., Kochanek, P. M., and Clark, R. S. (2010) Evaluation of 
autophagy using mouse models of brain injury. Biochim. Biophys. Acta 
1802, 918 –923 
65. Juhász, G., Erdi, B., Sass, M., and Neufeld, T. P. (2007) Atg7-dependent 
autophagy promotes neuronal health, stress tolerance, and longevity but is 
dispensable for metamorphosis in Drosophila. Genes Dev. 21, 3061–3066 
66. Petroi, D., Popova, B., Taheri-Talesh, N., Irniger, S., Shahpasandzadeh, H., 
Zweckstetter, M., Outeiro, T. F., and Braus, G. H. (2012) Aggregate clear-
ance of -synuclein in Saccharomyces cerevisiae depends more on au-
tophagosome and vacuole function than on the proteasome. J. Biol. Chem. 
287, 27567–27579 
67. Miller-Fleming, L., Giorgini, F., and Outeiro, T. F. (2008) Yeast as a model 
for studying human neurodegenerative disorders. Biotechnol. J. 3, 
325–338 
68. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, 
Hsp31 Is a Stress Response Chaperone 
OCTOBER 9, 2015 • VOLUME 290 • NUMBER 41 DASBMB JOURNAL OF BIOLOGICAL CHEMISTRY 24833 
L. J., Caldwell, K. A., Caldwell, G. A., Rochet, J. C., McCaffery, J. M., Bar-
lowe, C., and Lindquist, S. (2008) The Parkinson’s disease protein -sy-
nuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. U.S.A. 
105, 145–150 
69. Tenreiro, S., Reimão-Pinto, M. M., Antas, P., Rino, J., Wawrzycka, D., 
Macedo, D., Rosado-Ramos, R., Amen, T., Waiss, M., Magalhães, F., 
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